Pervasive functional translation of noncanonical human open reading frames.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
06 03 2020
Historique:
received: 26 05 2019
revised: 22 11 2019
accepted: 13 01 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 20 3 2020
Statut: ppublish

Résumé

Ribosome profiling has revealed pervasive but largely uncharacterized translation outside of canonical coding sequences (CDSs). In this work, we exploit a systematic CRISPR-based screening strategy to identify hundreds of noncanonical CDSs that are essential for cellular growth and whose disruption elicits specific, robust transcriptomic and phenotypic changes in human cells. Functional characterization of the encoded microproteins reveals distinct cellular localizations, specific protein binding partners, and hundreds of microproteins that are presented by the human leukocyte antigen system. We find multiple microproteins encoded in upstream open reading frames, which form stable complexes with the main, canonical protein encoded on the same messenger RNA, thereby revealing the use of functional bicistronic operons in mammals. Together, our results point to a family of functional human microproteins that play critical and diverse cellular roles.

Identifiants

pubmed: 32139545
pii: 367/6482/1140
doi: 10.1126/science.aay0262
pmc: PMC7289059
mid: NIHMS1590480
doi:

Substances chimiques

Peptides 0
RNA, Messenger 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1140-1146

Subventions

Organisme : NIGMS NIH HHS
ID : K99 GM134154
Pays : United States
Organisme : NIGMS NIH HHS
ID : R00 GM134154
Pays : United States
Organisme : NHGRI NIH HHS
ID : RM1 HG009490
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Nat Methods. 2017 Mar;14(3):297-301
pubmed: 28099430
Methods. 2017 Aug 15;126:112-129
pubmed: 28579404
Nature. 2017 Jan 26;541(7638):494-499
pubmed: 28077873
Science. 2016 Jan 15;351(6270):271-5
pubmed: 26816378
Science. 2014 Feb 14;343(6172):1248636
pubmed: 24407481
Elife. 2016 Sep 23;5:
pubmed: 27661255
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Science. 2012 Nov 23;338(6110):1088-93
pubmed: 23180859
Science. 2014 Jan 3;343(6166):80-4
pubmed: 24336569
Genome Res. 1997 Aug;7(8):768-71
pubmed: 9267801
Mol Cell. 2015 Dec 3;60(5):816-827
pubmed: 26638175
Science. 2010 Jul 16;329(5989):336-9
pubmed: 20647469
Sci Rep. 2017 Apr 13;7(1):880
pubmed: 28408736
Nucleic Acids Res. 2017 Jul 3;45(W1):W458-W463
pubmed: 28407089
Mol Cell. 2017 Oct 5;68(1):171-184.e6
pubmed: 28985503
Science. 2017 Apr 21;356(6335):323-327
pubmed: 28386024
Nat Methods. 2015 Aug;12(8):767-72
pubmed: 26121403
BMC Genomics. 2016 Nov 22;17(1):958
pubmed: 27875984
EMBO J. 2014 May 2;33(9):981-93
pubmed: 24705786
Nat Chem Biol. 2017 Feb;13(2):174-180
pubmed: 27918561
Genome Res. 2015 Aug;25(8):1147-57
pubmed: 26063738
Genes Dev. 2011 Sep 15;25(18):1915-27
pubmed: 21890647
Nat Commun. 2017 Aug 29;8(1):370
pubmed: 28851864
Science. 2016 Jan 29;351(6272):aad3867
pubmed: 26823435
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3501-8
pubmed: 27274053
Cell Rep. 2018 Jun 26;23(13):3710-3720.e8
pubmed: 29949756
J Biol Chem. 2014 Apr 18;289(16):10950-7
pubmed: 24610814
Cell Rep. 2018 Jun 26;23(13):3701-3709
pubmed: 29949755
EMBO Rep. 2011 Jun;12(6):565-73
pubmed: 21508961
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Cell. 2015 Feb 12;160(4):595-606
pubmed: 25640239
Cell Stem Cell. 2016 Apr 7;18(4):541-53
pubmed: 26971820
Nature. 2019 Jun;570(7759):77-82
pubmed: 31086336
Nat Biotechnol. 2017 Apr;35(4):347-349
pubmed: 28263296
Mol Cell Proteomics. 2017 Apr;16(4):694-705
pubmed: 28126900
Mol Cell. 2017 Oct 5;68(1):210-223.e6
pubmed: 28985505
J Biol Chem. 2013 Jul 26;288(30):21824-35
pubmed: 23760502
Bioinformatics. 2011 Jul 1;27(13):i275-82
pubmed: 21685081
Cell. 2011 Nov 11;147(4):789-802
pubmed: 22056041
Cell. 1988 Jan 29;52(2):185-95
pubmed: 3277717
Biochemistry. 2018 Sep 25;57(38):5564-5575
pubmed: 30215512
EMBO J. 2016 Apr 1;35(7):706-23
pubmed: 26896445
Nat Methods. 2014 Mar;11(3):319-24
pubmed: 24487582
Elife. 2014 May 09;3:e01257
pubmed: 24842990
Elife. 2015 Dec 19;4:e08890
pubmed: 26687005
Nat Rev Mol Cell Biol. 2003 Jul;4(7):566-77
pubmed: 12838339
Elife. 2017 Oct 30;6:
pubmed: 29083303
Mol Cell Proteomics. 2018 Dec;17(12):2402-2411
pubmed: 30181344
RNA. 2017 Jul;23(7):1080-1087
pubmed: 28386015
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11269-74
pubmed: 15277680
Nature. 2018 Dec;564(7736):434-438
pubmed: 30542152
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
Cell Rep. 2014 Sep 11;8(5):1365-79
pubmed: 25159147
Nat Chem Biol. 2013 Jan;9(1):59-64
pubmed: 23160002
Mol Cell Proteomics. 2015 Mar;14(3):658-73
pubmed: 25576301
Nat Commun. 2016 May 24;7:11663
pubmed: 27216465
Cell. 2016 Dec 15;167(7):1867-1882.e21
pubmed: 27984733
J Biol Chem. 2014 Jan 17;289(3):1257-70
pubmed: 24293369
Cell. 2014 Oct 23;159(3):647-61
pubmed: 25307932
Nat Genet. 2015 Mar;47(3):199-208
pubmed: 25599403
Nat Commun. 2017 Jun 01;8:15664
pubmed: 28569745
Nat Protoc. 2017 Feb;12(2):255-278
pubmed: 28079879
Genomics. 1997 Nov 1;45(3):541-53
pubmed: 9367679
Science. 2013 Sep 6;341(6150):1116-20
pubmed: 23970561
Science. 2017 Jan 6;355(6320):
pubmed: 27980086
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57
pubmed: 22645348
Nature. 2017 Jan 12;541(7636):228-232
pubmed: 28024296
Proteins. 2012 Jul;80(7):1715-35
pubmed: 22411565
Cell. 2013 Feb 14;152(4):909-22
pubmed: 23394947

Auteurs

Jin Chen (J)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.

Andreas-David Brunner (AD)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.

J Zachery Cogan (JZ)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.

James K Nuñez (JK)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.

Alexander P Fields (AP)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.

Britt Adamson (B)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.

Daniel N Itzhak (DN)

Cell Atlas Initiative, Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

Jason Y Li (JY)

Cell Atlas Initiative, Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

Matthias Mann (M)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.
Clinical Proteomics Group, Proteomics Program, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen 2200, Denmark.

Manuel D Leonetti (MD)

Cell Atlas Initiative, Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.

Jonathan S Weissman (JS)

Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA. jonathan.weissman@ucsf.edu.
Howard Hughes Medical Institute, University of California, San Francisco, CA 94158, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH